PROXY CORNER: Eli Lilly and Co.

Eli Lilly and Co., Lilly Corporate Center, Indianapolis, 46285 ( discovers, develops, manufactures and sells pharmaceutical products for humans and animals. The company reported 2010 net income of $5.1 billion, or $4.58 per diluted share, on revernue of $23.1 billion. That compares with 2009 net income of $4.3 billion, or $3.94 per diluted share, on $21.8 billion in revenue. The company’s shares trade on the New York Stock Exchange under the ticker symbol LLY. Information for Proxy Corner was taken from Yahoo! Finance and from the company’s proxy statement dated March 7, 2011. View full Proxy Corner feature

Please enable JavaScript to view this content.

Editor's note: IBJ is now using a new comment system. Your Disqus account will no longer work on the IBJ site. Instead, you can leave a comment on stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Past comments are not currently showing up on stories, but they will be added in the coming weeks. Please note our updated comment policy that will govern how comments are moderated.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets in {{ count_down }} days.